Eramel, Junrel, Jr. A.
HRN: 26-05-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2024
METRONIDAZOLE 500MG (TAB)
10/18/2024
10/24/2024
PO
500
Q8
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes